Showing results (931-940 of 1,115) with videos related to

Sort By:
Pageof 112
Molecular Cancer Research : MCR|March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL CellsUri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.
Cancer|February 6, 2003
Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosisHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Microbiology Spectrum|June 22, 2023
The Impact of Long-Term Macrolide Exposure on the Gut Microbiome and Its Implications for Metabolic ControlJocelyn M Choo, Alyce M Martin, Steven L Taylor, et al.
Carcinogenesis|November 21, 2009
Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancerSylwia E Wojcik, Simona Rossi, Masayoshi Shimizu, et al.
British Journal of Haematology|May 1, 1997
Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host diseaseI F Khouri, D Przepiorka, K van Besien, et al.
Blood|April 30, 2014
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cellsUri Rozovski, Ji Yuan Wu, David M Harris, et al.
Leukemia|May 3, 2023
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRDPhilip A Thompson, Michael J Keating, Alessandra Ferrajoli, et al.
Gait & Posture|November 27, 2020
Analysis of dynamic balance in preschool children through the balance beam test: A cross-sectional study providing reference valuesPedro A Latorre-Román, Melchor Martínez-Redondo, Juan A Párraga-Montilla, et al.
American Journal of Clinical Pathology|August 19, 2010
High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemiaSergej N Konoplev, Herbert A Fritsche, Susan O'Brien, et al.
Blood|September 27, 2018
A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemiaLisa S Chen, Prithviraj Bose, Nichole D Cruz, et al.
Pageof 112